Sfoglia per Autore
68 Ga-DOTA-TOC PET/CT of von Hippel-Lindau Disease
2019-01-01 Liberini, Virginia; Nicolotti, Daniele Giovanni; Maccario, Mauro; Finessi, Monica; Deandreis, Désirée
Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy
2019-01-01 Parasiliti-Caprino M.; Lucatello B.; Lopez C.; Burrello J.; Maletta F.; Mistrangelo M.; Migliore E.; Tassone F.; La Grotta A.; Pia A.; Reimondo G.; Giordano R.; Giraudo G.; Piovesan A.; Ciccone G.; Deandreis D.; Limone P.; Orlandi F.; Borretta G.; Volante M.; Mulatero P.; Papotti M.; Aimaretti G.; Terzolo M.; Morino M.; Pasini B.; Veglio F.; Ghigo E.; Arvat E.; Maccario M.
Update of the recommendations of good clinical practice for the use of PET in oncology
2019-01-01 Salaun P.-Y.; Abgral R.; Malard O.; Querellou-Lefranc S.; Quere G.; Wartski M.; Coriat R.; Hindie E.; Taieb D.; Tabarin A.; Girard A.; Grellier J.-F.; Brenot-Rossi I.; Groheux D.; Rousseau C.; Deandreis D.; Alberini J.-L.; Bodet-Milin C.; Itti E.; Casasnovas O.; Kraeber-Bodere F.; Moreau P.; Philip A.; Balleyguier C.; Lucian A.; Cachin F.
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial
2019-01-01 Morris M.J.; Loriot Y.; Sweeney C.J.; Fizazi K.; Ryan C.J.; Shevrin D.H.; Antonarakis E.S.; Pandit-Taskar N.; Deandreis D.; Jacene H.A.; Vesselle H.; Petrenciuc O.; Lu C.; Carrasquillo J.A.; Higano C.S.
Hyperglycemia and 18F-FDG PET/CT, issues and problem solving: a literature review
2019-01-01 Finessi M.; Bisi G.; Deandreis D.
Major limits of dosimetrically determined activities in advanced differentiated thyroid carcinoma
2019-01-01 Finessi M.; Liberini V.; Deandreis D.
Parathyroid Glands Hyperplasias Mimicking Medullary Thyroid Carcinoma Metastatic Lymph Nodes on 18F-DOPA PET/CT
2019-01-01 Terroir M.; Grimaldi S.; Hartl D.; Leboulleux S.; Deandreis D.
F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients
2019-01-01 Terroir M.; Caramella C.; Borget I.; Bidault S.; Dromain C.; El Farsaoui K.; Deandreis D.; Grimaldi S.; Lumbroso J.; Berdelou A.; Hadoux J.; Hescot S.; Hartl D.; Baudin E.; Schlumberger M.; Leboulleux S.
Interventional locoregional treatment and metabolic response: advantages of using PET/CT in the evaluation of response to treatment
2018-01-01 Finessi, Monica; Bellò, Marilena; Giunta, Francesca P; Veltri, Andrea; Deandreis, Désirée
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial
2018-01-01 Schlumberger, Martin; Leboulleux, Sophie; Catargi, Bogdan; Deandreis, Desiree; Zerdoud, Slimane; Bardet, Stephane; Rusu, Daniela; Godbert, Yann; Buffet, Camille; Schvartz, Claire; Vera, Pierre; Morel, Olivier; Benisvy, Danielle; Bournaud, Claire; Toubert, Marie-Elisabeth; Kelly, Antony; Benhamou, Ellen; Borget, Isabelle
Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: are there unsuspecting confounders?
2018-01-01 Finessi, Monica; Nicolotti, Daniele Giovanni; Bisi, Gianni; Deandreis, Désirée
Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of18F-Fluorocholine PET/CT
2018-01-01 Grimaldi, Serena*; Young, Jacques; Kamenicky, Peter; Hartl, Dana; Terroir, Marie; Leboulleux, Sophie; Berdelou, Amandine; Hadoux, Julien; Hescot, Segolene; Remy, Hervé; Baudin, Eric; Schlumberger, Martin; Deandreis, Désirée
Impact of Radioguided Occult Lesion Localization (ROLL) in the management of cervical recurrences from differentiated thyroid cancer.
2017-01-01 Deandreis D
Nuclear Oncology. Diagnostic Applications of Nuclear Medicine: Colorectal Cancer
2017-01-01 Ettore Pelosi, Désirée Deandreis, Laura Cassalia, Daniele Penna
Reply: Fixed 3.7-GBq 131I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History.
2017-01-01 Deandreis D
Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids.
2017-01-01 Sullivan, I; Le Teuff, G; Guigay, J; Caramella, C; Berdelou, A; Leboulleux, S; Déandréis, Désirée; Hadoux, J; Ducreux, M; Duvillard, P; Adam, J; Scoazec, Jy; Baudin, E; Planchard, D.
Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
2017-01-01 Lamartina, L; Borget, I; Mirghani, H; Al Ghuzlan, A; Berdelou, A; Bidault, F; Deandreis, Désirée; Baudin, E; Travagli, Jp; Schlumberger, M; Hartl, Dm; Leboulleux, S.
Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients
2017-01-01 Hadoux, J; Terroir, M; Leboulleux, S; Deschamps, F; Al Ghuzlan, A; Hescot, S; Tselikas, L; Borget, I; Caramella, C; Deandreis, Désirée; Goere, D; De Baere, T; Schlumberger, M; Baudin, E.
Reply: Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details.
2017-01-01 Deandreis Désirée
The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer
2017-01-01 Terroir, M1; Borget, I2; Bidault, F3; Ricard, M4; Deschamps, F5; Hartl, D6; Tselikas, L5; Dercle, L7; Lumbroso, J7; Baudin, E7; Berdelou, A7; Deandreis, Désirée; Schlumberger, M7; Leboulleux, S7
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 68 Ga-DOTA-TOC PET/CT of von Hippel-Lindau Disease | 2019 | Liberini, Virginia; Nicolotti, Daniele Giovanni; Maccario, Mauro; Finessi, Monica; Deandreis, Désirée | |
| Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy | 2019 | Parasiliti-Caprino M.; Lucatello B.; Lopez C.; Burrello J.; Maletta F.; Mistrangelo M.; Migliore E.; Tassone F.; La Grotta A.; Pia A.; Reimondo G.; Giordano R.; Giraudo G.; Piovesan A.; Ciccone G.; Deandreis D.; Limone P.; Orlandi F.; Borretta G.; Volante M.; Mulatero P.; Papotti M.; Aimaretti G.; Terzolo M.; Morino M.; Pasini B.; Veglio F.; Ghigo E.; Arvat E.; Maccario M. | |
| Update of the recommendations of good clinical practice for the use of PET in oncology | 2019 | Salaun P.-Y.; Abgral R.; Malard O.; Querellou-Lefranc S.; Quere G.; Wartski M.; Coriat R.; Hindie E.; Taieb D.; Tabarin A.; Girard A.; Grellier J.-F.; Brenot-Rossi I.; Groheux D.; Rousseau C.; Deandreis D.; Alberini J.-L.; Bodet-Milin C.; Itti E.; Casasnovas O.; Kraeber-Bodere F.; Moreau P.; Philip A.; Balleyguier C.; Lucian A.; Cachin F. | |
| Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial | 2019 | Morris M.J.; Loriot Y.; Sweeney C.J.; Fizazi K.; Ryan C.J.; Shevrin D.H.; Antonarakis E.S.; Pandit-Taskar N.; Deandreis D.; Jacene H.A.; Vesselle H.; Petrenciuc O.; Lu C.; Carrasquillo J.A.; Higano C.S. | |
| Hyperglycemia and 18F-FDG PET/CT, issues and problem solving: a literature review | 2019 | Finessi M.; Bisi G.; Deandreis D. | |
| Major limits of dosimetrically determined activities in advanced differentiated thyroid carcinoma | 2019 | Finessi M.; Liberini V.; Deandreis D. | |
| Parathyroid Glands Hyperplasias Mimicking Medullary Thyroid Carcinoma Metastatic Lymph Nodes on 18F-DOPA PET/CT | 2019 | Terroir M.; Grimaldi S.; Hartl D.; Leboulleux S.; Deandreis D. | |
| F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients | 2019 | Terroir M.; Caramella C.; Borget I.; Bidault S.; Dromain C.; El Farsaoui K.; Deandreis D.; Grimaldi S.; Lumbroso J.; Berdelou A.; Hadoux J.; Hescot S.; Hartl D.; Baudin E.; Schlumberger M.; Leboulleux S. | |
| Interventional locoregional treatment and metabolic response: advantages of using PET/CT in the evaluation of response to treatment | 2018 | Finessi, Monica; Bellò, Marilena; Giunta, Francesca P; Veltri, Andrea; Deandreis, Désirée | |
| Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial | 2018 | Schlumberger, Martin; Leboulleux, Sophie; Catargi, Bogdan; Deandreis, Desiree; Zerdoud, Slimane; Bardet, Stephane; Rusu, Daniela; Godbert, Yann; Buffet, Camille; Schvartz, Claire; Vera, Pierre; Morel, Olivier; Benisvy, Danielle; Bournaud, Claire; Toubert, Marie-Elisabeth; Kelly, Antony; Benhamou, Ellen; Borget, Isabelle | |
| Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: are there unsuspecting confounders? | 2018 | Finessi, Monica; Nicolotti, Daniele Giovanni; Bisi, Gianni; Deandreis, Désirée | |
| Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of18F-Fluorocholine PET/CT | 2018 | Grimaldi, Serena*; Young, Jacques; Kamenicky, Peter; Hartl, Dana; Terroir, Marie; Leboulleux, Sophie; Berdelou, Amandine; Hadoux, Julien; Hescot, Segolene; Remy, Hervé; Baudin, Eric; Schlumberger, Martin; Deandreis, Désirée | |
| Impact of Radioguided Occult Lesion Localization (ROLL) in the management of cervical recurrences from differentiated thyroid cancer. | 2017 | Deandreis D | |
| Nuclear Oncology. Diagnostic Applications of Nuclear Medicine: Colorectal Cancer | 2017 | Ettore Pelosi, Désirée Deandreis, Laura Cassalia, Daniele Penna | |
| Reply: Fixed 3.7-GBq 131I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History. | 2017 | Deandreis D | |
| Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids. | 2017 | Sullivan, I; Le Teuff, G; Guigay, J; Caramella, C; Berdelou, A; Leboulleux, S; Déandréis, Désirée; Hadoux, J; Ducreux, M; Duvillard, P; Adam, J; Scoazec, Jy; Baudin, E; Planchard, D. | |
| Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors. | 2017 | Lamartina, L; Borget, I; Mirghani, H; Al Ghuzlan, A; Berdelou, A; Bidault, F; Deandreis, Désirée; Baudin, E; Travagli, Jp; Schlumberger, M; Hartl, Dm; Leboulleux, S. | |
| Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients | 2017 | Hadoux, J; Terroir, M; Leboulleux, S; Deschamps, F; Al Ghuzlan, A; Hescot, S; Tselikas, L; Borget, I; Caramella, C; Deandreis, Désirée; Goere, D; De Baere, T; Schlumberger, M; Baudin, E. | |
| Reply: Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details. | 2017 | Deandreis Désirée | |
| The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer | 2017 | Terroir, M1; Borget, I2; Bidault, F3; Ricard, M4; Deschamps, F5; Hartl, D6; Tselikas, L5; Dercle, L7; Lumbroso, J7; Baudin, E7; Berdelou, A7; Deandreis, Désirée; Schlumberger, M7; Leboulleux, S7 |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile